Pipeline
In keeping with our pioneering spirit, within hormone health, we are busy developing and launching new products in the fields of Obstetrics & Gynaecology and Urology, with the aim of making a positive difference to the lives of more people than ever. See below for an overview of our pipeline.
You'll see we're working in multiple therapy areas, and are bringing many much-needed treatments to market.
| Women's health | Prevalent conditions | Women's health Prevalent conditions Endometriosis | |
| Fertility | |||
| Miscarriage | |||
| Bacterial vaginosis | |||
| Menopause | |||
| HSDD | |||
| Rare disease | Rare disease Undisclosed | ||
| Mens's health | Prevalent conditions | Mens's health Prevalent conditions Testosterone deficiency | |
| Rare disease | Rare disease Undisclosed | ||
| Exploration phaseDisease & product exploration | Development phaseExploratory developmentConfirmatory development | Market shaping phaseFilling registrationPre-launch | Launch phaseGeomix roll out |
|---|---|---|---|
| Dienogest 2mg | |||
| Utrogestan 300 mg | |||
| P4 (new dosing) | |||
| Nitro-5-imidazol | |||
P4 (new formulation) E2 | |||
| Testosterone | |||
| P4 | |||
| Testosterone (new route) | Testosterone (China) Testosterone (new route) | ||
| DHT |